Sri Any Sulistyowati and Budi Suprapti and Benny Gufron (2013) Pharmaceutical care and anti-hypertension treatment at trf-ht patients undergoing regular hemodialysis. a study at hemodialysis room, dr haryoto hospital, lumajang, east java, indonesia. Folia Medica Indonesiana, 49 (3). pp. 186-192. ISSN 0303-7932

	Text (FULLTEXT) Artikel C-18.pdf Download (4MB)
	Text (PEER REVIEW) Validasi C-18.pdf Download (1MB)

Abstract

Pharmaceutical care is important for patients who received drug therapy, especially patients with terminal renal failure withhypertension (TRF-HT) who underwent hemodialysis. Pathophysiological conditions of HT patients and usage of anti-hypertensivemedications (AHT) is a combination that raises potential problems related to drug (DRPs). The purpose of the study was to assessthe types of DRPs TRF-HT in patients undergoing HD and assessed PC intervention and interventions received doctor, nurses, andpatients. This study was prospective observational cohort analytic type. Each patient underwent TRF-HT regular HD would beaccompanied by the intervension of the PC and AHT medication for 8 weeks. Samples were taken by 36 TRF-HT patients who gotintervension of PC every undergoing HD. HD frequency maximum of 2 times per week. Discovered 275 DRPs with the majority ofpatients can experience >1 DRPs related AHT drug. Classification and percentage of DRPs according to the American Society ofHealth-System Pharmacist (AHSP) 1998 is as follows: untreated indication 4%, 3% improper drug selection, sub therapeutic dosage1%, failure to receive medication 27%, overdosage 4%, adverse drug side reaction (ESO) 37%, drug interaction 24%, medicationuse without indication 0%. One hundred of PC intervention doctor with details of consultation 75%, communication 9%, andsuggestions 16%. PC intervention in patients or families patients in form counseling information education as much as 219 times,84% IEC accepted. TRF-HT patients who underwent regular HD and administration of AHT potentially experiencing DRPs and PCimproves drug therapy appropriately.(FMI 2013;49:186-192)

Actions (login required)

View Item